Aliases: None
Indications: Symptomatic hypoglycemia, altered mentation with glucose < 60, newborn with heart rate < 60 and glucose < 40.
Contraindications: In suspected hypoglycemia: None
Concentrations:
Injection: 25g/250mL (1g/10mL)
Dosing
Adult:
| Indication | Dose | Route | Note |
| Symptomatic Hypoglycemia | 25g | IV Infusion | Titrate to effect. Repeat PRN |
Pediatric:
| Indication | Dose | Route | Note |
| Pediatric Hypoglycemia (30 days or older) | 1 g/kg (5mL/kg) | IV Infusion | Titrate to effect. Repeat PRN |
| Newborn Hypoglycemia (0-29 days) | 0.2 g/kg (1mL/kg) | IV Infusion | Titrate to effect. Repeat PRN |
Precautions: Use with caution in patients with suspected increased ICP.
Adverse/Side Effects: Patients may complain of warmth, pain, or burning at the injection site. Extravasation causes necrosis. Infusing through larger vessels decreases the risk of necrosis
Class: Carbohydrate
Mechanism of Action: Glucose is readily processed in the blood. Through glycolysis, glucose is turned into pyruvate giving off a small amount of chemical energy (ATP). Pyruvate is further processed through the Citric Acid Cycle yielding even more energy. Glucose is a large molecule and is incapable of being absorbed into a cell without insulin and therefore increases damage to epithelium. It also causes an osmotic pressure as concentrations vary across membranes.
| Onset of Action | Peak Effect | Duration of Action |
| Fast | Varies | Varies |